AI assistant
Exicon Co., Ltd. — AGM Information 2016
Feb 23, 2016
16401_rns_2016-02-23_5c56dc13-362c-49e1-8432-9b60490ebd0f.pdf
AGM Information
Open in viewerOpens in your device viewer
==> picture [114 x 46] intentionally omitted <==
Announcement No. 4/2016
To Nasdaq Copenhagen
Exiqon A/S Skelstedet 16 2950 Vedbæk Denmark
Phone: +45 4566 0888 Fax: +45 4566 1888 [email protected] www.exiqon.com CVR/Tax Id: 18 98 44 31
23 February 2016
Exiqon calls for ordinary general meeting
Exiqon A/S (Nasdaq Copenhagen: “EXQ”) calls for the ordinary general meeting to be held on Wednesday 16 March 2015 at 3 pm (CET) at the company’s address, Skelstedet 16, 2950 Vedbaek, Denmark. A copy of the notice with the complete proposals is attached hereto and can also be seen at www.exiqon.com .
Additional information
Lars Kongsbak, CEO, phone +45 4566 0888 (cell: +45 4090 2101) Hans Henrik Chrois Christensen, CFO, phone +45 4566 0888 (cell: +45 4090 2131)
About Exiqon
At Exiqon, we advance the research of when and where genes are expressed. We empower scientists across the world with best-in-class products and user-friendly business solutions designed to transform workflows in our industry. Exiqon operates in two business areas: Exiqon Life Sciences is a leading provider of flexible solutions for gene expression analysis. Academia, biotech and pharmaceutical companies around the world use Exiqon’s research products to make ground-breaking discoveries. Exiqon Diagnostics collaborates with diagnostic and pharmaceutical companies to develop novel molecular diagnostic tests for early detection of diseases, which can help physicians make better treatment decisions. Exiqon is listed on Nasdaq Copenhagen. For more information about us, please visit www.exiqon.com
==> picture [591 x 68] intentionally omitted <==
1/1